Maximize Profitability
with Manufacturing Analysis

“62% of drug shortages are caused by manufacturing and quality.”¹

Manufacturing processes can impede your ability to meet time-to-market and time-to-patients timelines.

Stop relying on disparate, labor-intensive, and error-prone data aggregation and analysis technologies across disparate data sources and manufacturing networks.

Gain regulatory compliance, accelerate improved collaboration, and reduce process variability, business risks, and costs.

“Meeting Pharma Manufacturing Challenges”

Regulatory Compliance Process Improvement Cost Containment

Do you have visibility into your manufacturing process performance?

Life sciences organizations and manufacturers are required to meet Continued Process Verification (CPV) requirements.

Gain visibility into processes with ad-hoc statistical investigations. Automatically aggregate and contextualize the data. Ensure GMP-relevant decisions are validated with full traceability and integrity.

90% reduction in time to prepare APQRs
60-70% reduction in validation efforts
50% reduction in FDA on-site inspection time

Download “Achieving the State of Control”

How to achieve product quality, profitability, and risk management?

Identify and optimize Critical Process Parameters (CPPs). Maximize efficiency and reduce costs. Optimize product yield and quality. Avoid batch deviations and failures. Minimize raw materials and energy consumption.

20-40% reduction in raw material consumption
Up to $500K in scrap avoidance
10-15% increase in productivity at manufacturing site

See performance achieved by Pacira

How to keep treatment prices affordable for patients in need?

Reduce non-value-added activities. Learn from data and act on it. Automate the creation of performance dashboards. Compare outcomes at different sites with different products. Monitor processes at Contract Manufacturing Organizations (CMOs). Assure data integrity and compliance.